Core Viewpoint - The article discusses the recent agreement between the U.S. Treasury and the G7, which exempts U.S. companies from certain foreign taxes in exchange for the withdrawal of the proposed Section 899, also known as the "retaliatory tax" [1][3]. Group 1: Agreement Details - The U.S. Treasury estimates that the agreement will prevent U.S. companies from paying over $100 billion in taxes to foreign governments over the next decade [3]. - The G7 will work to implement the agreement in the coming weeks to months, ensuring that the OECD's second pillar tax does not apply to U.S. companies [3][4]. - The OECD's international tax reform framework includes two pillars, with the second pillar aiming to impose a global minimum tax rate of around 15% to curb tax avoidance [3][4]. Group 2: Political Context - The Section 899 proposal was drafted by Republican members of the House and supported by the White House, aimed at countering discriminatory taxes imposed by several countries on U.S. companies [3][4]. - The agreement reflects a significant difference in economic models between Anglo-American countries and continental European nations, with the former favoring lower tax rates [4]. Group 3: Market Reactions - The "retaliatory tax" raised concerns on Wall Street, as it could complicate foreign investment in the U.S. and negatively impact U.S. assets [6][7]. - International investors have increasingly concentrated their investments in U.S. assets, driven by a tech boom and a strong dollar, which has raised concerns about potential market corrections [8].

Core Insights - Altria Group, Inc. is committed to transitioning towards a smoke-free future, with a focus on its oral tobacco portfolio, particularly the on! nicotine pouch brand, which has shown significant growth in shipment volumes and market share [1][2][9] - The company's oral tobacco revenues increased by 0.5% to $654 million in Q1 2025, driven by pricing power despite macroeconomic challenges [2] - Altria faces challenges in the vapor segment, particularly after regulatory issues led to the discontinuation of its NJOY ACE product, but plans to introduce compliant alternatives [3][4] Oral Tobacco Performance - The on! nicotine pouch brand's shipment volumes rose 18% year-over-year, exceeding 39 million cans, and its market share in the oral tobacco category increased by 1.8 percentage points to 8.8% [1][9] - The nicotine pouch market share for on! reached 17.9%, indicating strong consumer loyalty and brand strength despite retail price increases [1] Vapor Segment Challenges - Regulatory setbacks have impacted Altria's vapor products, leading to the discontinuation of NJOY ACE, but the company is working on launching new compliant products to regain market share [3][4] Competitive Landscape - Altria competes with Philip Morris International and British American Tobacco in the smoke-free category, both of which are also focusing on reduced-risk products [5][6][7] - Philip Morris reported a 20.4% increase in net revenues and a 33.1% rise in smoke-free gross profit, with significant growth in its ZYN and VEEV products [6] - British American Tobacco aims for 50 million consumers by 2030 and reported a 2.5% increase in New Category revenues in 2024 [7] Financial Performance and Valuation - Altria's stock has gained 12.5% year-to-date, while the industry has grown by 37.7% [8] - The company trades at a forward price-to-earnings ratio of 10.76X, below the industry average of 15.36X [11] - Earnings estimates for 2025 and 2026 suggest year-over-year growth of 4.9% and 3.3%, respectively, with recent upward revisions [12]

Core Insights - Clearmind Medicine Inc. has added Hadassah-University Medical Center in Jerusalem as a new clinical site for its Phase I/IIa trial of CMND-100, a drug candidate for Alcohol Use Disorder (AUD) [1][2] - The trial aims to evaluate the safety, tolerability, and pharmacokinetics of CMND-100, while also assessing its potential to reduce alcohol cravings and consumption [3] - Alcohol Use Disorder affects over 280 million people globally, indicating a significant unmet medical need and a potential multibillion-dollar market opportunity [4] Company Overview - Clearmind is a clinical-stage biotech company focused on developing psychedelic-derived therapeutics to address major health issues, including AUD [6] - The company holds an intellectual property portfolio consisting of nineteen patent families and 31 granted patents, with plans to seek additional patents as needed [7] Clinical Trial Details - The inclusion of Hadassah-University Medical Center is expected to enhance patient recruitment, accelerate data collection, and increase the statistical power of the study [3][5] - Other participating institutions include Yale School of Medicine, Johns Hopkins University, and Tel Aviv Sourasky Medical Center [2]

Market Performance - The cross-border payment (CIPS) concept declined by 1.95%, ranking among the top decliners in the concept sector [1] - Major decliners in the CIPS sector included Xiaogoods City, Jida Zhengyuan, and Xincheng Technology, while top gainers were Donghua Software, Jingbeifang, and *ST Rendo, with increases of 4.28%, 2.40%, and 2.34% respectively [1] Capital Flow - The CIPS concept experienced a net outflow of 6.149 billion yuan, with 47 stocks seeing net outflows, and 21 stocks exceeding 100 million yuan in net outflows [1] - Agricultural Bank led the net outflow with 759.39 million yuan, followed by Lakala, Xiaogoods City, and Industrial and Commercial Bank with outflows of 588.37 million yuan, 563.46 million yuan, and 485.34 million yuan respectively [1] Top Gainers and Losers - The top gainers in the CIPS sector included Donghua Software with a 4.28% increase, while the largest loser was Xiaogoods City with a 9.89% decrease [1] - Other notable losers included Agricultural Bank (-3.29%), Industrial and Commercial Bank (-2.85%), and Lakala (-2.44%) [2]

RT davo | drift (@davijlu)Drift's immediate plan is to be the best decentralised derivatives platform. Built on @solana at the L1 level to harness the global atomic state machine. No rollups or isolated environments.The benefit is asset availability. Drift is the only cross-margin perps DEX and this is only possible because of the L1. Products built on the L1 are directly downstream of asset issuance. You can expect an L1 like Solana to dominate in this area in the coming years.To date, Drift has $1 billion ...

Core Insights - The article discusses common pitfalls in growth strategies that companies often encounter, emphasizing the importance of understanding product-market fit and avoiding blind reliance on external growth tactics. Group 1: Common Growth Pitfalls - Companies often blame their go-to-market (GTM) strategy for product failures, neglecting the need for genuine product-market fit (PMF) before scaling [7][10]. - Relying solely on a growth team to reverse declining performance is ineffective; identifying core issues within the product or organization is crucial [13][15]. - Companies mistakenly believe that rebranding will lead to immediate growth, but such efforts often yield minimal short-term results [19][21]. Group 2: Misguided Strategies - Copying competitors' successful strategies can lead to mediocrity, as each company's context and customer base are unique [24][28]. - Companies often perceive their growth challenges as unique, overlooking the fact that many have faced similar issues and can provide valuable insights [29][31]. - Over-reliance on third-party channels for customer acquisition can be detrimental; companies should focus on building their own channels [33][35]. Group 3: Growth Model Limitations - Sticking to a single growth model without adaptation can lead to diminishing returns; companies must continuously explore new strategies [38][40]. - Companies often attempt to handle all challenges internally, missing out on the benefits of external expertise and insights [43][45]. - Excessive focus on A/B testing can slow down progress; a balance between data-driven decisions and intuitive understanding of the market is necessary [48][49]. Group 4: Key Growth Strategies - Implementing growth loops instead of traditional funnel thinking can create sustainable growth engines [56]. - Utilizing the racecar framework helps categorize different growth activities and their interrelations [57][60]. - Engaging adjacent users can unlock new growth opportunities without needing to expand the existing PMF [61].

Jahanvi Sardana on how startups reshape markets at All Stage | TechCrunch https://t.co/xhp9t5gF1e ...

Why a16z VC believes that Cluely, the ‘cheat on everything’ startup, is the new blueprint for AI startups | TechCrunch https://t.co/eVkLZREy1Y ...

AI Engineering Career Development - Identifies 10 GitHub repositories for building a career in AI engineering [1] - Highlights a 100% free roadmap for AI engineering [1] Key Areas in AI/ML - Covers basics of AI/ML [1] - Includes neural networks [1] - Focuses on research paper implementations [1] - Addresses MLOps [1] - Encompasses LLMs/RAG/Agents [1]

COIN ripping today on the US perps news+7% to $380 and a new ATH https://t.co/KasgyAsj1d ...